A new project at The Neuro, McGill University and the Research Institute of the McGill University Health Centre (RI-MUHC) has been awarded $10.6M in financial support as part of the Canada Foundation for Innovation’s (CFI) Innovation Fund.
A $6M grant from Brain Canada will fund the creation of a new Open Science patient registry, to share data with researchers around the world and let patients see how their data is used to develop new treatments for neurological disorders.
Today the Canadian Institutes of Health Research (CIHR) announced funding for a new clinical trial consortium co-chaired by Dr. Guy Rouleau, Director of The Neuro (Montreal Neurological Hospital-Institute).
The Neuro’s director, Dr. Guy Rouleau, has been elected first vice-president of the World Federation of Neurology. The first vice-president and other WFN officers are elected by delegates from its 122 neurological societies around the world.
The mission of the WFN is to foster quality neurology and brain health worldwide by promoting global neurological education and training with emphasis placed firmly on under-resourced parts of the world.
Doctor has dedicated his life to improve diagnosis and treatment of neurological diseases and disorders
The Neuro’s director, Dr. Guy Rouleau, is being recognized with Canada’s highest civilian honour, the Order of Canada, for his outstanding contributions as a clinician-scientist and as a leader in health care.
A diverse group of eight scientists whose work has offered insight into how cells interact with each other and their environment, the genetic underpinnings of neurological disease and the transmission of the virus that causes AIDS, have been named this year’s winners of the Gairdner Awards — the country’s most prestigious biomedical research prizes. Among the winners is Guy Rouleau, director of the Montreal Neurological Institute and Hospital, who is this year’s recipient of the Gairdner Wightman Award, which recognizes scientific leadership in Canada.
The Neuro’s director has been a driving force in neurological disease research and Open Science leadership
Since 1957, The Gairdner Foundation has been recognizing the achievements of the world’s top researchers for their contributions to health science. This year, Dr. Guy Rouleau joins an elite group of scientists by receiving the Canada Gairdner Wightman Award.
Q1K: A collaborative undertaking involving 1,000 families to transform autism care
Variants found in this population may predispose to brain aneurysm
A new study has found that an Inuit population in Canada’s Arctic are genetically distinct from any known group, and certain genetic variants are correlated with brain aneurysm.
Scanner will deliver clear images of the nervous system in exceptional detail
Scientists will see the human nervous system in microscopic detail thanks to the installation of Canada’s first 7-Tesla whole-body magnetic resonance imaging (MRI) scanner on Feb. 5.
Discovery will aid diagnosis and development of treatments
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) and McGill University have identified novel genes associated with a specific form of schizophrenia.
Schizophrenia is a major psychiatric illness affecting one per cent of the population worldwide. Patients suffering from schizophrenia present delusions, hallucinations, abnormal behavior, impairment in daily life and cognitive deficits. Current treatments are insufficient in addressing all of these symptoms.
A look at the latest ALS research and clinical care at The Neuro
Amyotrophic lateral sclerosis (ALS) is a terrible disease with no known cure. Research at The Montreal Neurological Institute and Hospital (The Neuro) is uncovering data that could help find effective treatments for ALS.
Djavad Mowafaghian Foundation shares The Neuro’s open science vision to accelerate drug discovery and find new and effective treatments for autism spectrum disorders
